The landscape of global human immunodeficiency virus (HIV) prevention is undergoing a critical transformation following a landmark agreement between biopharmaceutical…
Read More
UK Health Watchdog Drafts Against Routine NHS Funding for Gilead’s Twice-Yearly HIV Prevention Injection Lenacapavir
The National Institute for Health and Care Excellence (NICE) has issued a preliminary recommendation against the routine NHS commissioning of…
Read More
